Data / Drug companies / Prodose, Inc.
Prodose, Inc.: 66 products in the FDA NDC directory, labeler code 68210
Prodose, Inc. (labeler code 68210) lists 66 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 43 drugs for further processing, 23 over the counter drugs. Its main marketing category is drugs for further processing. The newest product started marketing on July 31, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68210
- Products in commercial distribution
- 66
- Packages
- 83
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 23
- Flagged as original packager
- 23 of 23 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- January 5, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 43 | 65.2% |
| Generic drugs (ANDA) | 16 | 24.2% |
| Over the counter monograph drugs | 7 | 10.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 43 | 65.2% |
| Over the counter drugs | 23 | 34.8% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ibuprofen | 8 | 190 |
| Cetirizine hydrochloride | 4 | 119 |
| Diphenhydramine hydrochloride | 2 | 127 |
| Fexofenadine hydrochloride | 2 | 65 |
| Naproxen sodium | 1 | 100 |
| Guaifenesin | 1 | 123 |
| Loratadine | 1 | 125 |
| Tetrahydrozoline hydrochloride and polyethylene glycol 400 | 1 | 4 |
| Oxymetazoline hydrochloride | 1 | 64 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 23 | 34.8% |
| Tablet, film coated | 23 | 34.8% |
| Capsule, gelatin coated | 8 | 12.1% |
| Tablet | 6 | 9.1% |
| Tablet, coated | 2 | 3% |
| Capsule | 1 | 1.5% |
| Tablet, film coated, extended release | 1 | 1.5% |
| Solution/ drops | 1 | 1.5% |
| Spray | 1 | 1.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Acetaminophen, dextromethorphan hydrobromide | 68210-5078 | Capsule, liquid filled | Drugs for further processing | July 31, 2026 |
| Acetaminophen 250mg, aspirin 250mg and caffeine 65mg soft gelatin capsules(gel tabs) | 68210-5070 | Tablet, coated | Drugs for further processing | May 11, 2026 |
| Dextromethorphan hydrobromide | 68210-5060 | Capsule, liquid filled | Drugs for further processing | March 3, 2026 |
| Docusate sodium and sennosides | 68210-5066 | Capsule, liquid filled | Drugs for further processing | February 2, 2026 |
| Omega-3 fish oil | 68210-5069 | Capsule | Drugs for further processing | January 30, 2026 |
| Value Health by Prodose Eye Drops | 68210-5059 | Solution/ drops | Over the counter monograph drugs | September 29, 2025 |
| Guaifenesin,dextromethorphan hbr | 68210-5058 | Capsule, liquid filled | Drugs for further processing | September 16, 2025 |
| Oxymetazoline hydrochloride | 68210-5056 | Spray | Over the counter monograph drugs | September 3, 2025 |
| Diphenhydramine hydrochloride | 68210-5057 | Capsule, liquid filled | Over the counter monograph drugs | July 30, 2025 |
| Acetaminophen, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | 68210-5053 | Capsule, liquid filled | Over the counter monograph drugs | July 29, 2025 |
| Dextromethorphan hydrobromide | 68210-5054 | Capsule, liquid filled | Drugs for further processing | July 18, 2025 |
| Acetaminophen | 68210-5055 | Capsule, liquid filled | Drugs for further processing | July 17, 2025 |
| Acetaminophen, dextromethorphan hydrobromide, doxylamine succinate and phenylephrine hydrochloride | 68210-5050 | Capsule, liquid filled | Drugs for further processing | July 16, 2025 |
| Guaifenesin,dextromethorphan hbr | 68210-5044 | Capsule, liquid filled | Drugs for further processing | July 16, 2025 |
| Acetaminophen, dextromethorphan hbr, guaifenesin | 68210-5052 | Tablet, film coated | Drugs for further processing | July 7, 2025 |
| Acetaminophen, dextromethorphan hbr and doxylamine succinate | 68210-5062 | Capsule, liquid filled | Drugs for further processing | June 25, 2025 |
| Acetaminophen, dextromethorphan hbr ,guaifenesin | 68210-5061 | Capsule, liquid filled | Drugs for further processing | June 25, 2025 |
| Docusate sodium and sennosides | 68210-5051 | Capsule, liquid filled | Drugs for further processing | June 25, 2025 |
| Acetaminophen | 68210-5047 | Capsule, liquid filled | Drugs for further processing | June 12, 2025 |
| Diphenhydramine hydrochloride | 68210-5046 | Capsule, liquid filled | Drugs for further processing | June 11, 2025 |
| Diphenhydramine hydrochloride | 68210-5045 | Capsule, liquid filled | Drugs for further processing | May 6, 2025 |
| Acetaminophen, dextromethorphan hbr and phenylephrine hcl | 68210-5064 | Capsule, liquid filled | Drugs for further processing | April 9, 2025 |
| Acetaminophen, dextromethorphan hydrobromide and doxylamine succinate | 68210-5042 | Capsule, liquid filled | Drugs for further processing | April 9, 2025 |
| Guaifenesin and dextromethorphan hbr | 68210-5041 | Capsule, gelatin coated | Drugs for further processing | April 9, 2025 |
| Allergy Relief | 68210-4230 | Tablet, film coated | Generic drugs (ANDA) | November 16, 2022 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.